---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-078031"
form_type: "8-K"
ticker: "MLTX"
cik: "0001821586"
company_name: "MoonLake Immunotherapeutics"
filed_at: "2026-07-14T21:31:54+00:00"
generated_at: "2026-07-15T10:05:37.216151+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# MoonLake Immunotherapeutics raises additional $30M from underwriters' overallotment exercise

## Summary
- Underwriters exercised in full their option to purchase 1,500,000 additional ordinary shares.
- Gross proceeds of $30.0 million from the sale of the option shares, before underwriting discounts.
- Closing of the option share issuance occurred on July 14, 2026.
- The option was part of a previously announced public offering of ordinary shares and pre-funded warrants.

## SEC filing metadata
- accession: 0001213900-26-078031
- form_type: 8-K
- ticker: MLTX
- cik: 0001821586
- company_name: MoonLake Immunotherapeutics
- filed_at: 2026-07-14T21:31:54+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1821586/000121390026078031/0001213900-26-078031-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1821586/000121390026078031/ea0298054-8k_moonlake.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-078031
- JSON: https://secwatch.observer/filing/0001213900-26-078031.json
- Plain text: https://secwatch.observer/filing/0001213900-26-078031.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.